Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Moreau

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Bioorganic & Medicinal Chemistry Letters|October 27, 2010
Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitorsEmmanuel Pinard, Daniela Alberati, Markus Bender, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2011
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activityFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Biological Psychiatry|June 19, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeuticsFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2015
Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depressionLothar Lindemann, Richard H Porter, Sebastian H Scharf, et al.
Journal of Medicinal Chemistry|May 25, 2010
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophreniaEmmanuel Pinard, Alexander Alanine, Daniela Alberati, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 11, 2007
[The prostate: how to treat this symbol of male vulnerability? An Association Française d'Urologie (AFU)-IPSOS qualitative survey]Bardon Yves, Alexandre de la Taille, Emmanuel Chartier-Kastler, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Bioorganic & Medicinal Chemistry Letters|October 27, 2010
Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitorsEmmanuel Pinard, Daniela Alberati, Markus Bender, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2011
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activityFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Biological Psychiatry|June 19, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeuticsFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2015
Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depressionLothar Lindemann, Richard H Porter, Sebastian H Scharf, et al.
Journal of Medicinal Chemistry|May 25, 2010
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophreniaEmmanuel Pinard, Alexander Alanine, Daniela Alberati, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 11, 2007
[The prostate: how to treat this symbol of male vulnerability? An Association Française d'Urologie (AFU)-IPSOS qualitative survey]Bardon Yves, Alexandre de la Taille, Emmanuel Chartier-Kastler, et al.
Pageof 6